Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Biotricity Inc. (BTCY)

2.99   -0.16 (-5.08%) 01-19 08:12
Open: 3.1 Pre. Close: 3.15
High: 3.1207 Low: 2.94
Volume: 217,022 Market Cap: 147M
Biotricity, Inc., medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated electrocardiogram (ECG) device and software solution. The company is based in Redwood City, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.125 - 3.147 3.147 - 3.163
Low: 2.885 - 2.913 2.913 - 2.935
Close: 2.95 - 2.989 2.989 - 3.019

Technical analysis

as of: 2022-01-18 4:29:54 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 5.14     One year: 6.19
Support: Support1: 2.94    Support2: 2.45
Resistance: Resistance1: 4.40    Resistance2: 5.30
Pivot: 3.70
Moving Average: MA(5): 3.24     MA(20): 3.79
MA(100): 3.69     MA(250): 3.10
MACD: MACD(12,26): -0.27     Signal(9): -0.17
Stochastic oscillator: %K(14,3): 4.03     %D(3): 6.59
RSI: RSI(14): 30.98
52-week: High: 5.30  Low: 1.13  Change(%): 115.1
Average Vol(K): 3-Month: 42950  10-Days: 25816

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
BTCY has closed above bottom band by 11.3%. Bollinger Bands are 95% wider than normal. The large width of the bands suggest high volatility as compared to BTCY's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Tue, 28 Dec 2021
Biotricity Stock (BTCY): Why The Price Increased Today - Pulse 2.0

Mon, 27 Dec 2021
Health Care Sector Update for 12/27/2021: MBOT, BTCY, SYK, BBIO - Nasdaq

Mon, 27 Dec 2021
Is Biotricity Inc (BTCY) Stock a Bad Value? - InvestorsObserver

Tue, 07 Dec 2021
Biotricity, a Leader in Remote Cardiac Health Monitoring Solutions, Issues Company Roadmap in 2021 Shareholder Letter - Yahoo Finance

Thu, 04 Nov 2021
Biotricity Releases Fiscal 2022 Second Quarter Financial Results - Yahoo Finance

Fri, 22 Oct 2021
Premarket Mover: Biotricity Inc (BTCY) Up 5.75% - InvestorsObserver

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  MUTUAL_FUND
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 48
Shares Float (M) 37
% Held by Insiders 11.31
% Held by Institutions 0.29
Shares Short (K) 1,130
Shares Short P. Month (K) 514

Stock Financials

EPS -0.678
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.160
Profit Margin
Operating Margin -262.92
Return on Assets (ttm) -118.2
Return on Equity (ttm) -4100.8
Qtrly Rev. Growth 142.7
Gross Profit (p.s.) 0.032
Sales Per Share 0.121
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -12
Levered Free Cash Flow (M) -4

Stock Valuations

PE Ratio -4.41
PEG Ratio
Price to Book value 18.69
Price to Sales 24.74
Price to Cash Flow -11.43

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.